Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma
Year: 2020
Type: article
Study design: Clinical Trial
Source: Annals of Surgical Oncology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Xencor, Burroughs Wellcome Fund, Conquer Cancer Foundation, Genentech Foundation for Biomedical Sciences, Amgen, Novartis, Roche, Celgene, AbbVie, Array BioPharma, Exelixis, Celldex Therapeutics, Parker Institute for Cancer Immunotherapy, MedImmune, National Institutes of Health, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases
Awards: G1470797798, Functional Manipulation of Memory Regulatory T cells in Skin, G1768458217, G2359412822, G261769834, G2645243329, Elucidating the Fundamental Biology of Memory Regulatory T cells in Skin, Research Training in Gastrointestinal Surgery, G7026078766, Mechanisms of immune regulation in the skin, Integrating targeted and immunotherapy to treat genetically heterogeneous cancers
OpenAlex ID: W3031620301
